Home > News > Nanobac Pharmaceuticals, Inc. Announces Confirming Results
February 23rd, 2004
Nanobac Pharmaceuticals, Inc. Announces Confirming Results
Abstract:
Nanobac Pharmaceuticals, Inc. is pleased to announce the publication of independent research which confirms and validates Dr.'s Kajander and Ciftcioglu's findings of the living organism, Nanobacteria Sanguineum, as a causal agent in the formation of kidney stones.
Source:
Businesswire
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||